Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q2 2021 Results – Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q2 2021 Results Earnings Conference Call August 5, 2021 5:00 PM ET
Company Participants
Richard Vincent – Chief Financial Officer
James Breitmeyer – President, Chief Executive Officer
Salim Yazji – Chief Medical Officer
…
